Key result
An integrated risk factor approach combining conventional predictors, carotid ultrasound phenotypes, and artificial intelligence may improve cardiovascular disease risk assessment in patients with CKD.
Why the study?
Conventional CVD risk prediction models do not consider atherosclerotic plaque-based phenotypes and can underestimate or overestimate CVD risk in CKD patients.
Does the integration of estimated glomerular filtration rate, ultrasonic image phenotypes, and artificial intelligence improve cardiovascular disease risk assessment in patients with chronic kidney disease compared to conventional models?
Does the integration of estimated glomerular filtration rate, ultrasonic image phenotypes, and artificial intelligence improve cardiovascular disease risk assessment in patients with chronic kidney disease compared to conventional models?
Answers are grounded in this paper and cite their sources.
Integrating eGFR, carotid ultrasound phenotypes, and artificial intelligence may improve the accuracy of cardiovascular risk assessment in patients with chronic kidney disease by overcoming the limitations of conventional models.
Chronic kidney disease (CKD) and cardiovascular disease (CVD) together result in an enormous burden on global healthcare. The estimated glomerular filtration rate (eGFR) is a well-established biomarker of CKD and is associated with adverse cardiac events. This review highlights the link between eGFR reduction and that of atherosclerosis progression, which increases the risk of adverse cardiovascular events. In general, CVD risk assessments are performed using conventional risk prediction models. However, since these conventional models were developed for a specific cohort with a unique risk profile and further these models do not consider atherosclerotic plaque-based phenotypes, therefore, such models can either underestimate or overestimate the risk of CVD events. This review examined the approaches used for CVD risk assessments in CKD patients using the concept of integrated risk factors. An integrated risk factor approach is one that combines the effect of conventional risk predictors and non-invasive carotid ultrasound image-based phenotypes. Furthermore, this review provided insights into novel artificial intelligence methods, such as machine learning and deep learning algorithms, to carry out accurate and automated CVD risk assessments and survival analyses in patients with CKD.
No takes yet. Share an insight, caveat, or question.
Jamthikar et al. (2021) conducted a review in Chronic kidney disease and cardiovascular disease. Integrated risk factor approach and artificial intelligence was evaluated. An integrated risk factor approach combining conventional predictors, carotid ultrasound phenotypes, and artificial intelligence may improve cardiovascular disease risk assessment in patients with CKD.
Synapse has enriched 10 related papers. Consider them for comparative context: